Actively Recruiting
Risk of Gastric Cancer in High-risk Helicobacter Pylori Carriers An Observational Cohort Study Comparing Cancer Incidence and Precancerous Lesion Progression
Led by Fudan University · Updated on 2026-02-25
3000
Participants Needed
1
Research Sites
547 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective observational cohort study to compare the occurrence of gastric cancer and the progression of precancerous stomach lesions among groups with different Helicobacter pylori (Hp) single nucleotide polymorphism (SNP) subtypes. The study focuses on people who initially have a negative gastric endoscopy and distinguishes between those carrying high-risk Hp SNP subtypes and those with non-high-risk subtypes. The main goal is to assess differences in gastric cancer incidence during follow-up, as well as to observe how precancerous lesions develop over time in these groups. The study involves following asymptomatic individuals who carry either high-risk or non-high-risk Hp SNP subtypes. Participants will be observed over a 3-year period without any active intervention, with researchers monitoring the incidence of gastric cancer and changes in gastric precancerous lesions such as atrophic gastritis and intestinal metaplasia. The study also aims to explore how factors like age, gender, diet, smoking, alcohol use, and family history may influence the risk associated with these Hp subtypes. During the study, participants will undergo baseline and follow-up examinations, including gastric endoscopy, to track the development of gastric cancer and precancerous changes. Researchers will collect data on various risk factors and monitor participants for 3 years from enrollment to measure differences in cancer incidence across the groups. The study excludes those with prior gastric cancer or certain health conditions that could limit participation or survival, ensuring a focused evaluation of risks in this population.
CONDITIONS
Official Title
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 40 years or older
- Any gender
- Able and willing to provide informed consent
- Willing to undergo baseline and follow-up examinations
You will not qualify if you...
- History of diagnosed gastric cancer or other digestive tract cancers
- Severe heart, lung, liver, or kidney conditions likely to shorten life or prevent long-term follow-up
- Severe mental illness or inability to participate due to lack of civil behavior
- Pregnant or breastfeeding women
- Other conditions deemed inappropriate by the investigator for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
People's Hospital of Tongling City
Tongling, China
Actively Recruiting
Research Team
D
Dazhi Xu, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here